Eyal Flom
Directeur/Bestuurslid bij INNOCAN PHARMA CORPORATION
Vermogen: 501 183 $ op 31-05-2024
Actieve functies van Eyal Flom
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INNOCAN PHARMA CORPORATION | Directeur/Bestuurslid | 25-09-2019 | - |
| Bedrijfssecretaris | 22-01-2020 | - | |
| REVIUM RECOVERY INC. | Directeur/Bestuurslid | - | - |
| Israeli Pharmaceutical Association | Algemeen Adviseur | 01-04-1995 | - |
NurExone Biologic Ltd.
 NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Directeur/Bestuurslid | - | - |
Loopbaan van Eyal Flom
Eerdere bekende functies van Eyal Flom
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NUREXONE BIOLOGIC INC. | Directeur/Bestuurslid | 15-06-2022 | 08-05-2023 |
Opleiding van Eyal Flom
| University of Derby | Masters Business Admin |
| Tel-Aviv University | Graduate Degree |
Statistieken
Internationaal
| Israël | 6 |
| Canada | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Director/Board Member | 4 |
| Corporate Secretary | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| INNOCAN PHARMA CORPORATION | Health Technology |
| NUREXONE BIOLOGIC INC. | Health Technology |
| REVIUM RECOVERY INC. | Distribution Services |
| Bedrijven in privébezit | 2 |
|---|---|
| Israeli Pharmaceutical Association | |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Health Technology |
